MIDD+ 2021 Conference Evolution: Evolving relationship between M&S and pharma R&D
- Model “supported” (questions 20 years ago):
–Do you think modeling and simulation might help?
- Model “based” (questions 5 years ago):
–How can I maximize the value of modeling and simulation in my development program?
- Model “informed” (questions today):
–How do I change the entire R&D process to reflect the availability of M&S tools and techniques?
By John DiBella, Jonathan Chauvin
Presented at SLP MIDD+ Virtual Conference March 3-4, 2021